Keith Norris to Risk Assessment
This is a "connection" page, showing publications Keith Norris has written about Risk Assessment.
Connection Strength
1.278
-
Streja E, Norris KC, Budoff MJ, Hashemi L, Akbilgic O, Kalantar-Zadeh K. The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease. Curr Opin Nephrol Hypertens. 2021 01; 30(1):38-46.
Score: 0.158
-
Yan G, Shen JI, Harford R, Yu W, Nee R, Clark MJ, Flaque J, Colon J, Torre F, Rodriguez Y, Georges J, Agodoa L, Norris KC. Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 States. Clin J Am Soc Nephrol. 2020 01 07; 15(1):101-108.
Score: 0.147
-
Norris KC, Duru OK, Alicic RZ, Daratha KB, Nicholas SB, McPherson SM, Bell DS, Shen JI, Jones CR, Moin T, Waterman AD, Neumiller JJ, Vargas RB, Bui AAT, Mangione CM, Tuttle KR. Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD. BMC Nephrol. 2019 11 20; 20(1):416.
Score: 0.146
-
Harford R, Clark MJ, Yan G, Flaque J, Colon J, Torre F, Rodriguez Y, Norris KC. Regional Variations in the Interpretation of the End-Stage Renal Disease Thirty-Month Coordination Period: Potential Implications for Patient Care. J Health Care Poor Underserved. 2017; 28(4):1245-1253.
Score: 0.120
-
Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol. 2009 Sep; 4(9):1515-22.
Score: 0.072
-
Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009 Nov; 76(9):977-83.
Score: 0.072
-
Ferdinand KC, Norris KC. Eliminating disparities in hypertension, metabolic syndrome, kidney failure, and cardiovascular disease: basic science, clinical practice and community initiatives. Foreword. Ethn Dis. 2009; 19(4 Suppl 5):S5iii-iv.
Score: 0.069
-
Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul; 3(4):1144-51.
Score: 0.065
-
Norris K, Bourgoigne J, Gassman J, Hebert L, Middleton J, Phillips RA, Randall O, Rostand S, Sherer S, Toto RD, Wright JT, Wang X, Greene T, Appel LJ, Lewis J. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis. 2006 Nov; 48(5):739-51.
Score: 0.059
-
Amin AP, Whaley-Connell AT, Li S, Chen SC, McCullough PA, Kosiborod MN. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Apr; 61(4 Suppl 2):S12-23.
Score: 0.046
-
Chang TI, Li S, Chen SC, Peralta CA, Shlipak MG, Fried LF, Whaley-Connell AT, McCullough PA, Kurella Tamura M. Risk factors for ESRD in individuals with preserved estimated GFR with and without albuminuria: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 04; 61(4 Suppl 2):S4-11.
Score: 0.046
-
Contreras G, Hu B, Astor BC, Greene T, Erlinger T, Kusek JW, Lipkowitz M, Lewis JA, Randall OS, Hebert L, Wright JT, Kendrick CA, Gassman J, Bakris G, Kopple JD, Appel LJ. Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol. 2010 Dec; 21(12):2131-42.
Score: 0.039
-
Sinha SK, Shaheen M, Singh VR, Rajavashisth TB, Pan D, Sun L, Norris KC, Nicholas SB. How Clinically Relevant Is C-Reactive Protein for Blacks with Metabolic Syndrome to Predict Microalbuminuria? Metab Syndr Relat Disord. 2021 02; 19(1):39-47.
Score: 0.039
-
Weinberg JM, Appel LJ, Bakris G, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA. Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med. 2009 Sep 28; 169(17):1587-94.
Score: 0.036
-
Bruce MA, Beech BM, Norris KC, Griffith DM, Sims M, Thorpe RJ. Sex, Obesity, and Blood Pressure Among African American Adolescents: The Jackson Heart KIDS Pilot Study. Am J Hypertens. 2017 Sep 01; 30(9):892-898.
Score: 0.031
-
Mehrotra R, Peralta CA, Chen SC, Li S, Sachs M, Shah A, Norris K, Saab G, Whaley-Connell A, Kestenbaum B, McCullough PA. No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease. Kidney Int. 2013 Nov; 84(5):989-97.
Score: 0.023
-
Jurkovitz CT, Li S, Norris KC, Saab G, Bomback AS, Whaley-Connell AT, McCullough PA. Association between lack of health insurance and risk of death and ESRD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2013 Apr; 61(4 Suppl 2):S24-32.
Score: 0.023
-
Peralta CA, Norris KC, Li S, Chang TI, Tamura MK, Jolly SE, Bakris G, McCullough PA, Shlipak M. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2012 Jan 09; 172(1):41-7.
Score: 0.021
-
Jolly SE, Burrows NR, Chen SC, Li S, Jurkovitz CT, Norris KC, Shlipak MG. Racial and ethnic differences in mortality among individuals with chronic kidney disease: results from the Kidney Early Evaluation Program (KEEP). Clin J Am Soc Nephrol. 2011 Aug; 6(8):1858-65.
Score: 0.021
-
Fischer MJ, Kimmel PL, Greene T, Gassman JJ, Wang X, Brooks DH, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris KC, Lash JP. Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease. Kidney Int. 2010 Jun; 77(11):1010-9.
Score: 0.019
-
McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ, Chen SC, Li S, Singh A, Norris KC, Klag MJ, Bakris GL. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007 Jun 11; 167(11):1122-9.
Score: 0.015
-
Appel LJ, Middleton J, Miller ER, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT. The rationale and design of the AASK cohort study. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S166-72.
Score: 0.012